Importantly, we explored the mechanism of how DOR activation promotes breast cancer progression, finding strong induction of oncogenic JAK1/2-STAT3 signaling and epithelial-mesenchymal transition (EMT) markers. The gene discussed is STAT3; the disease is breast carcinoma.